Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KC-5128

Ba/F3-Mouse-JAK2-V617F-KI Cell Line

Home » Ba/F3-Mouse-JAK2-V617F-KI Cell Line

Background of Ba/F3-Mouse-JAK2-V617F-KI Cell Line

Janus kinase 2 (JAK2) is a critical non-receptor tyrosine kinase involved in cytokine signaling through the JAK-STAT pathway. In mice, JAK2 mediates responses to hematopoietic cytokines such as erythropoietin (EPO), thrombopoietin (TPO), and interleukins, playing essential roles in hematopoiesis, immune regulation, and cell proliferation. The constitutive activation of JAK2, particularly via the V617F mutation, is associated with myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Mouse models with JAK2 mutations have been instrumental in studying MPN pathogenesis and testing targeted therapies, such as JAK2 inhibitors (e.g., ruxolitinib). Additionally, JAK2 knockout studies in mice demonstrate its necessity for embryonic development, particularly in definitive erythropoiesis. Despite advances in understanding JAK2’s role, challenges remain in developing therapies that selectively inhibit mutant JAK2 without disrupting normal cytokine signaling. Further research using murine models is crucial for elucidating JAK2’s broader functions and improving therapeutic strategies for JAK2-related disorders.

Specifications

Catalog Number:
KC-5128
Cell Line Name:
Ba/F3-Mouse-JAK2-V617F-KI Cell Line
Clone Number
1A3
Host Cell Line:
Ba/F3
Description:
Stable Ba/F3 clone expressing endogenous Mouse JAK2 gene bearing V617F mutations, No.1A3
Quantity:
Two vials of frozen cells (2-5×106/vial)
Stability:
Stable in culture over a minimum of 10 passages
Application:
Drug screening and biological assays
Freezing Medium:
RPMI1640+20% FBS+10% DMSO
Propagation Medium:
RPMI1640+10% FBS
Selection Marker:
N/A
Morphology:
Mostly single, round (some polymorph) cells in suspension
Subculture:
Split saturated culture 1:4-1:6 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation:
37 °C with 5% CO2
Storage:
Liquid nitrogen immediately upon receiving
Doubling Time:
Approximately 30 hours
Mycoplasma Status:
Negative
In Vivo Validation:

Cell Line Generation

Ba/F3-Mouse-JAK2-V617F-KI cell line was generated using the CRISPR method.

Characterization

Figure 1: Characterization of Ba/F3-Mouse-JAK2-V617F-KI cell line stable clone using PCR sequencing.

Figure 2: Characterization of Ba/F3-Mouse-JAK2-V617F-KI cell line stable clone using RT-PCR sequencing.

Cell Resuscitation

  1. Prewarm culture medium (RPMI1640+10% FBS)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:4-1:6 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% RPMI1640 + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage

References

  1. Parganas, E., et al. (1998). Jak2 is essential for signaling through a variety of cytokine receptors. Cell, 93(3), 385-395.
  2. Baxter, E.J., et al. (2005). Acquired mutation of JAK2 in myeloproliferative disorders. The Lancet, 365(9464), 1054-1061.
  3. Mullally, A., et al. (2010). Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells. Cancer Cell, 17(6), 584-596.